The RANTES promoter polymorphism: A genetic risk factor for near-fatal asthma in Chinese children

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 6, 2003, Pages 1285-1292

  Yao, Tsung Chieh ^a   Kuo, Ming Ling ^a   See, Lai Chu ^b   Chen, Li Chen ^a   Yan, Dah Chin ^a   Ou, Liang Shiou ^a   Shaw, Cheng Kuang ^c   Huang, Jing Long ^a  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Asthma; Chemokine; Children; Chinese; Near fatal asthma; Polymorphism; RANTES

Indexed keywords

RANTES;

ALLERGIC ASTHMA; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL ASSAY; CELL COUNT; CHILD; CHINESE; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE SEVERITY; EOSINOPHIL; FATALITY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR;

EID: 0038179307     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1506     Document Type: Article

References (41)

1. Weiss ST. Epidemiology and heterogeneity of asthma. Ann Allergy Asthma Immunol 2001;87(Suppl):5-8.
2. Hsieh KH, Shen JJ. Prevalence of childhood asthma in Taipei, Taiwan, and other Asian Pacific countries. J Asthma 1988;25:73-82.
3. Kao CC, See LC, Yan DC, Ou LS, Hunag JL. Time trends and seasonal variations in hospital admissions for childhood asthma in Taiwan from 1990 to 1998. Asian Pacific J Allergy Immunol 2001;19:63-8.
4. Koppelman GH, Stine OC, Xu J, Howard TD, Zheng SL, Kauffman HF, et al. Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol 2002;109:498-506.
5. The Collaborative Study on the Genetics of Asthma (CSGA). A genomewide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997;15:389-92.
6. Dizier MH, Besse-Schmittler C, Guilloud-Bataille M, Annesi-Maesano I, Boussaha M, Bousquet J, et al. Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med 2000;162:1812-8.
7. Donlon TA, Krensky AM, Wallace MR, Collins FS, Lovett M, Clayberger C. Localization of a human T-cell-specific gene. RANTES (D17SI36E), to chromosome 17q11.2-q12. Genomics 1990;6:548-53.
8. Nelson PJ, Kim HT, Manning WC, Goralski TJ, Krensky AM. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 1993;151:2601-12.
9. Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 1997;158:4398-404.
10. Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M, et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 1999;163:6321-9.
11. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, et al. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996;153:1398-404.
12. Chihara J, Yasuba H, Tsuda A, Urayama O, Saito N, Honda K, et al. Elevation of the plasma level of RANTES during asthma attacks. J Allergy Clin Immunol 1997;100:S52-5.
13. Teran LM, Noso N, Carroll M, Davies DE, Holgate S, Schroder JM. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol 1996;157:1806-12.
14. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 1999;96:4581-5.
15. Nickel RG, Casolaro V, Wahn U, Deyer K, Barnes KC, Plunkett BS, et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000;164:1612-6.
16. Fryer AA, Spiteri MA, Bianco A, Hepple M, Jones PW, Strange RC, et al. The -403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 2000;1:509-14.
17. Szalai C, Kozma GT, Nagy A, Bojszko A, Krikovszky D, Szabo T, et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001;108:375-81.
18. Kozma GT, Falus A, Bojszko A, Krikovszky D, Szabo T, Nagy A, et al. Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1. Allergy 2002;57:160-3.
19. Weir TD, Mallek N, Sandford AJ, Bai TR, Awadh N, Fitzgerald JM, et al. β2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998;158:787-91.
20. McDermott DH, Beecroft MJ, Kleeberger CA, Al-Sharif FM, Ollier WE, Zimmerman PA, et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 2000;14:2671-8.
21. Takada T, Suzuki E, Ishida T, Moriyama H, Ooi H, Hasegawa T, et al. Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population. Tissue Antigens 2001;58:293-8.
22. Al Sharif F, Ollier WE, Hajeer AH. A rare polymorphism at position -28 in the human RANTES promoter. Eur J Immunogenet 1999;26:373-4.
23. Hajeer AH, Al Sharif F, Ollier WE. A polymorphism at position -403 in the human RANTES promoter. Eur J Immunogenet 1999;26:375-6.
24. Sandford AJ, Changani T, Zhu S, Whir TD, Bai TR, Spinelli JJ, et al. Polymorphisms in the IL-4, IL-4RA and FCERIB genes and asthma severity. J Allergy Clin Immunol 2000;106:135-40.
25. Tillie-Leblond I, Hammad H, Desurmont S, Pugin J, Wallaert B, Tonnel AB, et al. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment. Am J Respir Crit Care Med 2000;162:586-92.
26. NHLBI/WHO Workshop Report 2002. Global strategy for asthma management and prevention. National Institute of Health. National Heart, Lung, and Blood Institute. Publication No. 02-3659. Bethesda (MD): The Institute; 2002.
27. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients. Atherosclerosis 2001;158:233-9.
28. x on pulmonary function and methacholine and allergen bronchial sensitivities in asthmatic children. Arch Environ Health 1991;46:296-9.
29. Terwillinger JD, Ott J. Handbook of human genetic linkage. Baltimore (MD): John Hopkins University Press; 1994.
30. Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown MA, et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993;150:3442-7.
31. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
32. Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J 1997;10:292-300.
33. Lamblin C, Gosset P, Tillie-Leblond I, Saulnier F, Marquette CH, Wallaert B, et al. Bronchial neutrophilia inpatients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998;157:394-402.
34. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990;85:422-36.
35. Moriuchi H, Moriuchi M, Fauci AS. Nuclear factor-κB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 1997;158:3483-91.
36. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, Kaplan AP. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 1992;149:636-42.
37. Kimata BH, Yoshida A, Ishioka C, Fujimoto M, Lindley I, Furusho K. RANTES and macrophage inflammatory protein 1α selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J Exp Med 1996;183:2397-402.
38. Bacon KB, Premack BA, Gardner P, Schall TJ. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 1995;269:1727-9.
39. Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 1996;98:1016-8.
40. Richards G, Kolbe J, Fenwick J, Rea H. Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths. Thorax 1993;48:1105-9.
41. Wiesch DG, Samet JM. Epidemiology and natural history of asthma. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: Principles and practice. St Louis: Mosby; 1998. p. 799-815.